P-glycoprotein drug efflux pump involved in the mechanisms of intrinsic drug resistance in various colon cancer cell lines. Evidence for a saturation of active daunorubicin transport

Biochemical Pharmacology

Volumn 41, Issue 3, 1991, Pages 349-359

  Spoelstra, Ellen C ^a   Dekker, Henk ^a   Schuurhuis, Gerrit Jan ^a   Broxterman, Henricus J ^a   Lankelma, Jan ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CREMOPHOR; CYCLOSPORIN A; DAUNORUBICIN; GLYCOPROTEIN; N (3,4 DIMETHOXYPHENETHYL) N METHYL 2 (2 NAPHTHYL) 1,3 DITHIANE 2 PROPYLAMINE; VERAPAMIL;

ARTICLE; COLON CANCER; DRUG RESISTANCE; OVARY CANCER; PRIORITY JOURNAL;

ANIMAL; BINDING SITES; BIOLOGICAL TRANSPORT, ACTIVE; CELL SURVIVAL; COLONIC NEOPLASMS; COMPARATIVE STUDY; DAUNORUBICIN; DRUG RESISTANCE; FEMALE; GLYCEROL; HUMAN; MEMBRANE GLYCOPROTEINS; MICE; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; P-GLYCOPROTEIN; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED; VERAPAMIL;

EID: 0025966666     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(91)90531-9     Document Type: Article

References (59)

1. Experimental therapeutics and kinetics: selection and overgrowth of specifically and permanently drug-resistant tumor cells
2. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate
3. Cellular resistance to actinomycin D in chinese hamster cells in vitro: cross-resistance, radioautographic and cytogenetic studies
4. Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance
5. The biochemistry of P-glycoprotein-mediated multidrug resistance
6. Isolation and expression of a complementary DNA that confers multidrug resistance
7. ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells
8. Induction by verapamil of a rapid increase in ATP consumption in multidrug-resistant tumor cells
9. Expression of a multidrug-resistance gene in human tumors and tissues
10. Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics
11. Calcium channel blocker enhancement of anticancer drug cytotoxicity—a review
12. Possible link between the intrinsic drug resistance of colon tumors and a detoxification mechanism of intestinal cells
13. Phase I study of vinblastine and verapamil given by concurrent iv infusion
14. Verapamil and adriamycin in the treatment of drug-resistant ovarian cancer patients
15. Potentiation of doxorubicin cytotoxicity by the calcium antagonist bepridil in anthracycline-resistant and -sensitive cell lines
16. Effect of cyclosporin A on daunorubicin accumulation in multidrug-resistant P388 leukemia cells measured by real-time flow cytometry
17. Identification of anthracyclines and related agents that retain preferential activity over Adriamycin in multidrug-resistant cell lines, and further resistance modification by verapamil and cyclosporin A
18. Relationship between cytotoxicity drug accumulation DNA damage and repair of human ovarian cancer cells treated with doxorubicin modulation by the tiapamil analog RO11-2933
19. Promotion of daunorubucin uptake and toxicity by the calcium antagonist tiapamil and its analogs
20. The polyoxyethylene castor oil Cremophor EL modifies multidrug resistance
21. A flow-through tissue culture system with fast dynamic response
22. The effect of cyclosporin A and verapamil on daunomycin accumulation rate in the murine colon carcinoma cell line C-26
23. Cell lines from human colon carcinoma with unusual cell products, double minutes and homogeneously staining regions
24. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay
25. Identification of two distinct regulatory regions adjacent to the human b-interferon gene
26. A non-P-glycoprotein mediated mechanism for multidrug resistance precedes P-glycoprotein expression during in vitro selection for doxorubicin resistance in a human lung cancer cell line
27. Monoclonal antibody JSB-1 detects a highly conserved epitope on the P-glycoprotein associated with multidrug-resistance
28. Immunohistochemical detection of P-glycoprotein in human tumor cells with a low degree of drug resistance
29. Functional role for the 170- to 180- kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies
30. Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies
31. Production of monoclonal antibodies defining guinea pig T-cell surface markers and a strain 13 Ia-like antigen: the value of immunohistological screening
32. Daunomycin accumulation in resistant tumor cells as a screening model for resistance modifying drugs: role of protein binding
33. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil
34. Carrier-mediated transport of daunorubicin, adriamycin and rubidazone in Ehrlich ascites tumour cells
35. Increase of daunorubicin and vincristine accumulation in multidrug resistant human ovarian carcinoma cells by a monoclonal antibody reacting with P-glycoprotein
36. Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells
37. Cyclosporin A and its immunosuppressive analogs reverse Vinca alkaloid resistance by interacting with P-glycoprotein
38. Equilibrium, kinetic and photoaffinity labeling studies of daunomycin binding to P-glycoprotein-containing membranes of multidrug-resistant Chinese hamster ovary cells
39. Photoaffinity labeling of the multidrug-resistance-related P-glycoprotein with photoactive analogs of verapamil
40. Kinetic analysis of active efflux of vincristine from multidrug-resistant P388 leukemia cells
41. Saturable process involved in active efflux of vincristine as a mechanism of multidrug resistance in P388 leukemia cells
42. Doxorubicin resistance in P388 leukemia-evidence for reduced drug influx
43. Transport and binding of daunorubicin, adriamycin, and rubidazone in Ehrlich ascites tumour cells
44. Allosteric proteins and cellular control systems
45. Characteristics of doxorubicin transport in human red blood cells
46. A Fickian diffusion transport process with features of transport catalysis
47. On the nature of allosteric transitions: a plausible model
48. Drug transport in multidrug-resistant tumor cells—a revision of the pump-hypothesis
49. Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins
50. Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells
51. Cytoplasmic orientation and two-domain structure of the multidrug transporter, P-glycoprotein, demonstrated with sequence-specific antibodies
52. Two different regions of phosphoglycoprotein are photoaffinity-labeled by azidopine
53. Discrete mutations introduced in the predicted nucleotide-binding sites of the mdr1 gene abolish its ability to confer multidrug resistance